Merit Medical Systems Total Liabilities 2010-2023 | MMSI

Merit Medical Systems total liabilities from 2010 to 2023. Total liabilities can be defined as the total value of all possible claims against the corporation.
Merit Medical Systems Annual Total Liabilities
(Millions of US $)
2023 $1,123
2022 $520
2021 $608
2020 $706
2019 $807
2018 $687
2017 $435
2016 $445
2015 $313
2014 $312
2013 $323
2012 $324
2011 $90
2010 $134
2009 $53
Merit Medical Systems Quarterly Total Liabilities
(Millions of US $)
2023-12-31 $1,123
2023-09-30 $579
2023-06-30 $634
2023-03-31 $512
2022-12-31 $520
2022-09-30 $544
2022-06-30 $558
2022-03-31 $573
2021-12-31 $608
2021-09-30 $630
2021-06-30 $650
2021-03-31 $675
2020-12-31 $706
2020-09-30 $737
2020-06-30 $787
2020-03-31 $809
2019-12-31 $807
2019-09-30 $812
2019-06-30 $786
2019-03-31 $750
2018-12-31 $687
2018-09-30 $387
2018-06-30 $592
2018-03-31 $551
2017-12-31 $435
2017-09-30 $420
2017-06-30 $385
2017-03-31 $363
2016-12-31 $445
2016-09-30 $443
2016-06-30 $335
2016-03-31 $331
2015-12-31 $313
2015-09-30 $309
2015-06-30 $302
2015-03-31 $297
2014-12-31 $312
2014-09-30 $322
2014-06-30 $328
2014-03-31 $332
2013-12-31 $323
2013-09-30 $323
2013-06-30 $339
2013-03-31 $329
2012-12-31 $324
2012-09-30 $138
2012-06-30 $130
2012-03-31 $126
2011-12-31 $90
2011-09-30 $68
2011-06-30 $112
2011-03-31 $134
2010-12-31 $134
2010-09-30 $134
2010-06-30 $50
2010-03-31 $53
2009-12-31 $53
2009-09-30 $53
2009-06-30 $53
2009-03-31 $43
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $4.272B $1.257B
Merit Medical Systems, Inc. provides various peripheral and cardiac intervention products to cure cardiac conditions specific to interventional cardiology and electrophysiology. The company offers products focused in five core product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, cardiovascular and critical care as well as endoscopy. However, the company operates in two revenue segments: Cardiovascular and Endoscopy Devices.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $69.513B 20.18
McKesson (MCK) United States $68.775B 18.41
West Pharmaceutical Services (WST) United States $28.373B 47.97
Cardinal Health (CAH) United States $25.885B 15.56
Align Technology (ALGN) United States $24.450B 49.30
Cooper (COO) United States $19.104B 28.91
Labcorp (LH) United States $17.372B 14.84
Henry Schein (HSIC) United States $9.226B 15.96
DENTSPLY SIRONA (XRAY) United States $6.640B 17.50
STAAR Surgical (STAA) United States $2.521B 79.39
CONMED (CNMD) United States $2.342B 22.05
Patterson (PDCO) United States $2.305B 11.04
Atrion (ATRI) United States $0.709B 36.55
Lifevantage (LFVN) United States $0.078B 12.67
Pro-Dex (PDEX) United States $0.065B 24.53
Biolase (BIOL) United States $0.005B 0.00